Autologous peripheral blood stem cell transplantation as first line treatment of multiple myeloma: an Italian Multicenter Study. [electronic resource]
Producer: 20000414Description: 52-8 p. digitalISSN:- 0390-6078
- Adult
- Age Factors
- Antigens, CD34 -- therapeutic use
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Blood Component Removal
- Cyclophosphamide -- administration & dosage
- Cytarabine -- administration & dosage
- Dexamethasone -- administration & dosage
- Disease-Free Survival
- Erythrocyte Transfusion
- Evaluation Studies as Topic
- Follow-Up Studies
- Granulocyte Colony-Stimulating Factor -- administration & dosage
- Hematopoietic Stem Cell Transplantation
- Humans
- Infections -- etiology
- Italy
- Male
- Middle Aged
- Multiple Myeloma -- complications
- Myeloablative Agonists -- therapeutic use
- Neutrophils
- Platelet Count
- Prognosis
- Retrospective Studies
- Risk Factors
- Stem Cells
- Survival Rate
- Transplantation, Autologous
- Treatment Outcome
- Vincristine -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.